AXP
American Express CompanyClose $309.82EOD onlyThis page reflects AXP options positioning from the latest published market-close snapshot. Intraday price and contract changes are not displayed.
Historical consensus-supported lens with full content, report chain context, and metric rail.
Outlook
Neutral-to-bullish with a strong pinning regime centered near $300-$302.50. Confidence: 9/10. The strongest signals are the positive GEX ($+6.0M) creating a sticky range, net bullish premium flow, and spot aligning with near-term max pain levels. The primary conflict is the elevated IV (39.9%) suggesting expensive premium and the distant, massive call OI walls.
Conflicts: IV 39.9% is high, making premium buying expensive. Long-term max pain trend falls to $280, suggesting structural gravity lower.
Regime Classification
Price Range Forecast
Key Levels
Dealer Positioning (GEX/DEX)
GEX: $+6.0M
DEX: +5.3M shares
Gamma flip: ~$280 (Approx — based on put OI concentration of 4,634)
NTM gamma: Positive GEX concentrated near spot acts as a volatility dampener. A move **above $308** begins to test the 2d EM high, reducing pinning force. A move **below $297** approaches the 2d EM low and increases dealer hedging (selling) as spot nears the $280 gamma flip.
IV Analysis
IV vs VIX: IV 39.9% — elevated, no direct VIX given but context suggests rich vol.
Term structure: **Humped**: Near-term (4/2: 35.3%) < Mid-term (4/24-5/8: 40-43%) > Long-term (~36%). Kink at April/May expiries, likely pricing Q1 earnings (est. 4/23).
Skew: **Calendar opportunity**: Sell rich May vol (~43%) against buying cheaper June/July vol (~36%). 7+ vol-pt differential supports a reverse calendar for a bullish view.
Flow Analysis
Net premium: +$3.2M bullish; P/C vol 0.77 (balanced today), P/C OI 0.52 (structurally call-heavy).
Directional prints: **$250C** saw $683K net premium (likely bought calls for leverage). **$275C** saw $534K net premium (similar). Both are OTM, consistent with bullish speculation.
Unusual: **$150P Jan 2027** (Vol 224 vs OI 136, IV 48.9%) — deep OTM leap put bought for cheap long-term tail hedge or speculative bearish bet.
Risks & Catalysts
Strategy Viability
| Strategy | Edge | Best Setup | Primary Risk |
|---|---|---|---|
| Long Stock | Moderate | Buy shares at $302.48. | High IV and pinning limit near-term upside; break below $280 support. |
| Short Stock | Weak | Sell shares or short at $302.48. | Bullish flow, positive GEX, and pinning create upward drift pressure. |
| Covered Call | Moderate-Strong | Own shares, sell 4/17 $310 Call (~$8.00 est). | Capped upside if stock rallies past $318; shares decline unprotected. |
| Cash-Secured Put / Put Spread | Moderate-Strong | Sell 4/17 $295 Put (~$9.50 est) or $295/$290 Put Spread. | Assignment below strike; break below $290. |
| Long Calls | Moderate-Weak | Buy 4/17 $310 Call (~$8.00 est). | High IV (34%) and pinning regime hurt long premium; needs a strong breakout. |
| Long Puts / Bear Put Spread | Weak | Buy 4/17 $295 Put (~$9.50 est) or $295/$300 Put Spread. | Bullish flow and positive GEX oppose downside; high IV cost. |
| Iron Condor | Moderate | 4/17 $290/$285P x $315/$320C (outside 1w EM bounds). | GEX positive supports, but VIX context unknown and IV high adds tail risk. |
| Calendar / Diagonal | Moderate-Strong | **Reverse Calendar (Bullish)**: Sell 5/8 $310 Call (IV 43.4%), Buy 6/18 $310 Call (IV 36.4%). | Needs spot to hover near $310; earnings vol crush in short leg. |
| PMCC / LEAPS Diagonal | Moderate | Buy 2027 Jan $250 Call (~$68 est), Sell 4/17 $310 Call (~$8.00 est). | Capital intensive; short call caps upside in pinning regime. |
Top Plays
Watchlist Triggers
Tactical Summary
Each report translates the same market-close options snapshot into a specific lens such as directional bias, premium-selling posture, flow quality, or earnings setup.
Reports are most useful for narrowing the playbook, surfacing entry and risk context, and deciding which raw data page to inspect next.
These are interpretation layers, not execution guarantees. Validate the setup against chain liquidity, expected move, and exposure before sizing risk.